Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 87.05% is 12% above its 5-year average of 77.98%, near the high end of its 5-year range (56.51%–93.83%).
0.34% above its 12-month average of 86.76%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 89.75%.
GROSS MARGIN
87.05%
GROSS MARGIN AVG TTM
86.76%
GROSS MARGIN AVG 3Y
80.75%
GROSS MARGIN AVG 5Y
77.98%
GROSS MARGIN AVG 10Y
72.73%
GROSS MARGIN AVG 15Y
74.23%
GROSS MARGIN AVG 20Y
51.32%
CURRENT VS TTM AVG
+0.34%
CURRENT VS 3Y AVG
+7.81%
CURRENT VS 5Y AVG
+11.62%
CURRENT VS 10Y AVG
+19.69%
CURRENT VS 15Y AVG
+17.27%
CURRENT VS 20Y AVG
+69.62%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+110.37%
vs the sector median at left
Delcath Systems, Inc.
Market Cap
$535.09M
Gross Margin
87.05%
TTM Avg
86.76%
3Y Avg
80.75%
5Y Avg
77.98%
Market Cap
$535.16M
Gross Margin
82.92%
TTM Avg
86.33%
3Y Avg
62.04%
5Y Avg
41.36%
Market Cap
$534.18M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$536.32M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
50.00%
5Y Avg
33.33%
Market Cap
$538.63M
Gross Margin
-195.10%
TTM Avg
-90.32%
3Y Avg
-3207.95%
5Y Avg
-2168.95%
Market Cap
$523.62M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$546.91M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$520.84M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$520.25M
Gross Margin
73.28%
TTM Avg
79.19%
3Y Avg
65.08%
5Y Avg
51.90%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $535.09M | 87.05% | 86.76% | 80.75% | 77.98% |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $535.16M | 82.92% | 86.33% | 62.04% | 41.36% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $534.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| ProKidney Corp. (PROK)vs › | $536.32M | 100.00% | 100.00% | 50.00% | 33.33% |
| Shattuck Labs, Inc. (STTK)vs › | $538.63M | -195.10% | -90.32% | -3207.95% | -2168.95% |
| Immix Biopharma, Inc. (IMMX)vs › | $523.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| Monopar Therapeutics Inc. (MNPR)vs › | $546.91M | 0.00% | 0.00% | 0.00% | 0.00% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $520.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $520.25M | 73.28% | 79.19% | 65.08% | 51.90% |
| Altimmune, Inc. (ALT)vs › | $520.22M | 100.00% | 100.00% | 100.00% | 31.77% |
Gross Margin
87.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 89.75% |
| 2026-03-31 | 85.05% |
| 2025-12-31 | 85.48% |
| 2025-09-30 | 87.24% |
| 2025-06-30 | 86.26% |
| 2025-03-31 | 85.62% |
| 2024-12-31 | 85.92% |
| 2024-09-30 | 85.36% |
| 2024-06-30 | 80.44% |
| 2024-03-31 | 71.23% |
| 2023-12-31 | 68.27% |
| 2023-09-30 | 69.35% |
| 2023-06-30 | 69.70% |
| 2023-03-31 | 69.68% |
| 2022-12-31 | 62.91% |
| 2022-09-30 | 74.06% |
| 2022-06-30 | 77.42% |
| 2022-03-31 | 91.27% |
| 2021-12-31 | 93.83% |
| 2021-09-30 | 56.51% |
| 2021-06-30 | 62.31% |
| 2021-03-31 | 71.13% |
| 2020-12-31 | 59.37% |
| 2020-09-30 | 59.66% |
| 2020-06-30 | 55.67% |
| 2020-03-31 | 73.47% |
| 2019-12-31 | 46.03% |
| 2019-09-30 | 54.74% |
| 2019-06-30 | 58.25% |
| 2019-03-31 | 64.44% |
| 2018-12-31 | 60.02% |
| 2018-09-30 | 71.72% |
| 2018-06-30 | 74.36% |
| 2018-03-31 | 79.06% |
| 2017-12-31 | 75.28% |
| 2017-09-30 | 74.85% |
| 2017-06-30 | 76.88% |
| 2017-03-31 | 70.52% |
| 2016-12-31 | 73.82% |
| 2016-09-30 | 74.25% |
| 2016-06-30 | 70.65% |
| 2016-03-31 | 70.00% |
| 2015-12-31 | 76.77% |
| 2015-09-30 | 77.44% |
| 2015-06-30 | 70.60% |
| 2015-03-31 | 70.05% |
| 2014-12-31 | 72.16% |
| 2014-09-30 | 76.96% |
| 2014-06-30 | 73.71% |
| 2014-03-31 | 70.00% |
| 2013-12-31 | 76.92% |
| 2013-09-30 | 68.06% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 91.86% |
| 2012-12-31 | 80.50% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-10-21 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
